These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22922658)

  • 1. Short amyloid-β immunogens with spacer-enhanced immunogenicity without junctional epitopes for Alzheimer's disease immunotherapy.
    Guan X; Zou J; Gu H; Yao Z
    Neuroreport; 2012 Oct; 23(15):879-84. PubMed ID: 22922658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
    Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
    J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B; Rangel M; Hunter Z; Peabody DS
    Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing novel immunogens for an effective, safe Alzheimer's disease vaccine.
    Maier M; Seabrook TJ; Lemere CA
    Neurodegener Dis; 2005; 2(5):267-72. PubMed ID: 16909008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
    Lemere CA
    Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.
    Xing XN; Zhang WG; Sha S; Li Y; Guo R; Wang C; Cao YP
    Chin Med J (Engl); 2011 Sep; 124(17):2636-41. PubMed ID: 22040416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.
    Feng G; Wang W; Qian Y; Jin H
    J Neurosci Methods; 2013 Aug; 218(1):48-54. PubMed ID: 23701997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
    Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
    J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
    Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
    Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Abeta immunogens: is shorter better?
    Lemere CA; Maier M; Peng Y; Jiang L; Seabrook TJ
    Curr Alzheimer Res; 2007 Sep; 4(4):427-36. PubMed ID: 17908047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC-independent genetic factors control the magnitude of CD4+ T cell responses to amyloid-β peptide in mice through regulatory T cell-mediated inhibition.
    Toly-Ndour C; Lui G; Nunes MM; Bruley-Rosset M; Aucouturier P; Dorothée G
    J Immunol; 2011 Nov; 187(9):4492-500. PubMed ID: 21949026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
    Kim HD; Maxwell JA; Kong FK; Tang DC; Fukuchi K
    Biochem Biophys Res Commun; 2005 Oct; 336(1):84-92. PubMed ID: 16126169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes.
    Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL
    Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.
    Fu L; Li Y; Hu Y; Zheng Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
    Sci Rep; 2017 Jan; 7():41041. PubMed ID: 28106117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42.
    Axelsen TV; Holm A; Christiansen G; Birkelund S
    Vaccine; 2011 Apr; 29(17):3260-9. PubMed ID: 21371581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA.
    Hara H; Mouri A; Yonemitsu Y; Nabeshima T; Tabira T
    Vaccine; 2011 Oct; 29(43):7474-82. PubMed ID: 21803105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Antigenic Peptide System Coupled with Amyloid Beta Protein Epitopes As An Immunization Approach to Treat Alzheimer's Disease.
    Sun D; Qiao Y; Jiang X; Li P; Kuai Z; Gong X; Liu D; Fu Q; Sun L; Li H; Ding J; Shi Y; Kong W; Shan Y
    ACS Chem Neurosci; 2019 Jun; 10(6):2794-2800. PubMed ID: 31042358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.